Objectives include strengthening competitiveness for large, multi-disciplinary funding opportunities and expanding the university’s network of prospective stakeholders and partners across sectors.
A small molecule inhibitor is key to potentially reversing CTNNB1 syndrome, according to a new study from a School of Medicine professor and colleagues.
Eddie Qian, M27, shares his experience studying drug resistance in melanoma cells and lessons learned about the intersection of basic and clinical research.
$20 million NIH grant will support a team led by Tufts University School of Medicine researchers to enroll one of the U.S.’s largest prospective studies of Lyme disease patients.